MicroRNA expression profiles in supraglottic carcinoma

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2029-2034

  Zhang, Tianhong ^a   Han, Guojun ^a   Wang, Yansong ^a   Chen, Kewa ^a   Sun, Yanan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Microarray analysis; MicroRNAs; Supraglottic carcinoma

Indexed keywords

MICRORNA; MICRORNA 125B-2; MICRORNA 128A:9.1; MICRORNA 1299; MICRORNA 136; MICRORNA 19A; MICRORNA 206; MICRORNA 21; MICRORNA 218; MICRORNA 299-5P; MICRORNA 30A; MICRORNA 337-3P; MICRORNA 33A; MICRORNA 34B; MICRORNA 34C-3P; MICRORNA 375; MICRORNA 410; MICRORNA 432; MICRORNA 486-3P; MICRORNA 885-5P; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MALE; MICROARRAY ANALYSIS; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION; BIOLOGY; BIOSYNTHESIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; LARYNX TUMOR; MIDDLE AGED; PATHOLOGY; RNA PROCESSING; SQUAMOUS CELL CARCINOMA; SUPRAGLOTTITIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SUPRAGLOTTITIS;

EID: 84898655887     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3117     Document Type: Article

References (40)

1. Rudolph E, Dyckhoff G, Becher H, Dietz A and Ramroth H: Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: A systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268: 165-179, 2011
2. Cosetti M, Yu GP and Schantz SP: Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134: 370-379, 2008
3. Petrakos I, Kontzoglou K, Nikolopoulos TP, Papadopoulos O and Kostakis A: Glottic and supraglottic laryngeal cancer: Epidemiology, treatment patterns and survival in 164 patients. J BUON 17: 700-705, 2012
4. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004
5. Ferretti E, De Smaele E, Po A, et al: MicroRNA profiling in human medulloblastoma. Int J Cancer 124: 568-577, 2009
6. Khoshnaw SM, Green AR, Powe DG and Ellis IO: MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 62: 422-428, 2009
7. Raponi M, Dossey L, Jatkoe T, et al: MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783, 2009
8. Akao Y, Nakagawa Y and Naoe T: MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16: 845-850, 2006
9. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005
10. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003
11. Gentleman RC, Carey VJ, Bates DM, et al: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004
12. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P and Hatzigeorgiou AG: The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res 37: D155-D158, 2009
13. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M and Hatzigeorgiou AG: DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 25: 1991-1993, 2009
14. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005
15. Newman JC and Weiner AM: L2L: A simple tool for discovering the hidden significance in microarray expression data. Genome Biol 6: R81, 2005
16. Thompson JD, Higgins DG and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680, 1994
17. Kumar S, Nei M, Dudley J and Tamura K: MEGA: A biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9: 299-306, 2008
18. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006
19. Petrocca F, Visone R, Onelli MR, et al: E2F1-regulated microRNAs impair TGF?-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286, 2008
20. Bloomston M, Frankel WL, Petrocca F, et al: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908, 2007
21. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006
22. Liu M, Wu H, Liu T, et al: Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 19: 828-837, 2009
23. Avissar M, Christensen BC, Kelsey KT and Marsit CJ: MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855, 2009
24. Chang SS, Jiang WW, Smith I, et al: MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797, 2008
25. Tran N, McLean T, Zhang X, et al: MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358: 12-17, 2007
26. Adams BD, Furneaux H and White BA: The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-? (ER?) and represses ER? messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 1132-1147, 2007
27. Anderson C, Catoe H and Werner R: MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34: 5863-5871, 2006
28. Davis E, Caiment F, Tordoir X, et al: RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr Biol 15: 743-749, 2005
29. Garzon R, Pichiorri F, Palumbo T, et al: MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103: 5078-5083, 2006
30. Greco SJ and Rameshwar P: MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci USA 104: 15484-15489, 2007
31. Krek A, Grün D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005
32. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003
33. Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688, 2007
34. Meng F, Wehbe-Janek H, Henson R, Smith H and Patel T: Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 27: 378-386, 2008
35. Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230, 2004
36. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E and Tapscott SJ: MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 175: 77-85, 2006
37. Wang G, van der Walt JM, Mayhew G, et al: Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of ?-synuclein. Am J Hum Genet 82: 283-289, 2008
38. Wong TS, Liu XB, Chung-Wai Ho A, et al: Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 123: 251-257, 2008
39. Wu L and Belasco JG: Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol Cell Biol 25: 9198-9208, 2005
40. Ashburner M, Ball CA, Blake JA, et al: Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000